創薬における人工知能の市場調査レポート 2030年までの予測

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

創薬における人工知能の市場調査レポート 2030年までの予測市場概要創薬における人工知能市場は、予測期間中に29.83%の大幅なCAGRを記録すると予測される。創薬における模擬知能の受容の高まり、創薬におけ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年9月1日	US$7,250 ライセンス・価格情報注文方法はこちら	132	英語

目次
図表リスト

サマリー

創薬における人工知能の市場調査レポート 2030年までの予測

市場概要
創薬における人工知能市場は、予測期間中に29.83%の大幅なCAGRを記録すると予測される。創薬における模擬知能の受容の高まり、創薬における人工知能に対する主要イニシアチブの高まり、人工知能を搭載した創薬新企業の増加が、事業分野の発展を促進しています。
創薬におけるシミュレーテッド・インテリジェンスの評価は、製薬企業やバイオテクノロジー企業などの業界で高まっている。これは本質的に、人工知能が薬物粒子の発見に進歩した利点を提供し、創薬プロセスをペースアップさせる方法によるものである。さらに、人工知能は薬の設計、最適化、合成に取り組む上で重要な洞察を与えてくれる。創薬のための人工知能の受容を高めている要因はいくつかある。最も優勢なものは、病気の対策と治療に対処するための新たな方法による、進行中の病気と正確な医療の発生率の上昇を含む。その上、いくつかの市場メンバーは、薬剤ポートフォリオの精度を高めており、このサイクルが人工知能の進歩の受容の増加を示していると見られている。
市場の細分化
創薬における人工知能は、製品とサービスに基づいて、ソフトウェアとサービスに分類される。分子タイプに基づくと、市場は高分子と低分子に分けられる。技術に基づく創薬人工知能市場は、機械学習、ディープラーニング、その他に分類される。
適応症に基づくと、市場は免疫腫瘍学、神経変性疾患、心血管疾患、代謝性疾患、その他に分類される。用途に基づくと、市場は標的同定、候補スクリーニング、de novo薬剤設計、薬剤最適化と再利用、前臨床試験に分類される。
地域別洞察
北米の創薬人工知能市場は、2022年に最も大きなパイを占めた。これは、同地域で進行中の疾病が増加していること、多くの大手新興企業が参入していること、医薬品研究開発への投資が増加していることによる。
欧州の人工知能による創薬市場が2番目に大きなパイを占めているのは、欧州全域で珍しい病気が蔓延し、創薬のためのシミュレーテッド・インテリジェンス主導の段階への需要が高まっているためである。さらに、ドイツの人工知能市場
アジア太平洋地域の人工知能による創薬市場は、2023年から2030年にかけて大きな伸びを示すと予想されている。これは、アジア太平洋地域で、病気の重さが増していることと、コンピューターベースのインテリジェンス能力を採用するバイオ医薬品業界が非常に増えているためである。
世界のその他の地域は、中東、アフリカ、中南米に細分化される。先に述べた地域の創薬市場における人工知能は、おそらく、持続性疾患や感染性疾患の罹患率の上昇による医薬品需要の増加のため、発展を観察するつもりです。
主要企業
創薬における人工知能市場の主要企業には、IBM（米国）、Alphabet Inc（米国）、Atomwise Inc（米国）、Deep Genomics（カナダ）、Cloud Pharmaceuticals, Inc（米国）、Microsoft corporation（米国）、Insilico Medicine（中国）、Cyclica（カナダ）、BenevolentAI（英国）、Exscientia（英国）などがある。

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA MINING

3.3 SECONDARY RESEARCH

3.4 PRIMARY RESEARCH

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING ADOPTION OF AI IN DRUG DISCOVERY

4.2.2 RISING STRATEGIC INITIATIVES FOR AI IN DRUG DISCOVERY

4.2.3 INCREASING NUMBER OF AI-POWERED DRUG DISCOVERY START-UPS

4.3 RESTRAINTS

4.3.1 SHORTAGE OF AI WORKFORCE

4.4 OPPORTUNITIES

4.4.1 EMERGING MARKETS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL AI IN DRUG DISCOVERY

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON SERVICE DEMAND

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

6.1 OVERVIEW

6.2 SOFTWARE

6.3 SERVICES

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

7.1 OVERVIEW

7.2 LARGE MOLECULE

7.3 SMALL MOLECULE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 MACHINE LEARNING

8.3 DEEP LEARNING

8.4 OTHERS

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

9.1 OVERVIEW

9.2 IMMUNO-ONCOLOGY

9.3 NEURODEGENERATIVE DISEASES

9.4 CARDIOVASCULAR DISEASES

9.5 METABOLIC DISEASES

9.6 OTHERS

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 TARGET IDENTIFICATION

10.3 CANDIDATE SCREENING

10.4 DE NOVO DRUG DESIGNING

10.5 DRUG OPTIMIZATION AND REPURPOSING

10.6 PRECLINICAL TESTING

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 FRANCE

11.3.3 UK

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 CHINA

11.4.2 JAPAN

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

12.5 KEY DEVELOPMENT ANALYSIS

12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.6.1 SERVICE/COMPANY LAUNCH

12.6.2 MERGER/ACQUISITION

12.6.3 PARTNERSHIP/COLLABORATION/AGREEMENT

13 COMPANY PROFILES

13.1 IBM

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 SOFTWARE/SERVICES OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 ALPHABET INC.

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 SOFTWARE/SERVICES OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 ATOMWISE INC.

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 SOFTWARE/SERVICES OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 SWOT ANALYSIS

13.3.6 KEY STRATEGIES

13.4 DEEP GENOMICS

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 SOFTWARE/SERVICES OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 KEY STRATEGIES

13.5 CLOUD PHARMACEUTICALS, INC.

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 SOFTWARE/SERVICES OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 KEY STRATEGIES

13.6 MICROSOFT CORPORATION

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 SERVICES OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 INSILICO MEDICINE

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 SERVICES OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 KEY STRATEGIES

13.8 CYCLICA

13.8.1 COMPANY OVERVIEW

13.8.2 FINANCIAL OVERVIEW

13.8.3 SERVICES OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 KEY STRATEGIES

13.9 BENEVOLENTAI

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 SERVICES OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 EXSCIENTIA

13.10.1 COMPANY OVERVIEW

13.10.2 FINANCIAL OVERVIEW

13.10.3 SOFTWARES OFFERED

13.10.4 KEY DEVELOPMENTS

13.10.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

ページTOPに戻る

図表リスト

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 3 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRODUCT, BY REGION, 2019–2030 (USD BILLION)

TABLE 4 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SERVICES, BY REGION, 2019–2030 (USD BILLION)

TABLE 5 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 6 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR LARGE MOLECULE, BY REGION, 2019–2030 (USD BILLION)

TABLE 7 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SMALL MOLECULE, BY REGION, 2019–2030 (USD BILLION)

TABLE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR MACHINE LEARNING, BY REGION, 2019–2030 (USD BILLION)

TABLE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DEEP LEARNING, BY REGION, 2019–2030 (USD BILLION)

TABLE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 13 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR IMMUNO-ONCOLOGY, BY REGION, 2019–2030 (USD BILLION)

TABLE 14 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019–2030 (USD BILLION)

TABLE 15 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2030 (USD BILLION)

TABLE 16 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR METABOLIC DISEASES, BY REGION, 2019–2030 (USD BILLION)

TABLE 17 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 18 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 19 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2019–2030 (USD BILLION)

TABLE 20 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CANDIDATE SCREENING, BY REGION, 2019–2030 (USD BILLION)

TABLE 21 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DE NOVO DRUG DESIGNING, BY REGION, 2019–2030 (USD BILLION)

TABLE 22 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DRUG OPTIMIZATION AND REPURPOSING, BY REGION, 2019–2030 (USD BILLION)

TABLE 23 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRECLINICAL TESTING, BY REGION, 2019–2030 (USD BILLION)

TABLE 24 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION, 2019–2030 (USD BILLION)

TABLE 25 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 26 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 27 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 28 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 29 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 30 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 31 US AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 32 US AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 33 US AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 34 US AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 35 US AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 36 CANADA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 37 CANADA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 38 CANADA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 39 CANADA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 40 CANADA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 41 EUROPE: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 42 EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 43 EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 44 EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 45 EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 46 EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 47 GERMANY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 48 GERMANY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 49 GERMANY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 50 GERMANY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 51 GERMANY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 52 FRANCE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 53 FRANCE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 54 FRANCE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 55 FRANCE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 56 FRANCE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 57 UK AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 58 UK AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 59 UK AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 60 UK AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 61 UK AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 62 ITALY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 63 ITALY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 64 ITALY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 65 ITALY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 66 ITALY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 67 SPAIN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 68 SPAIN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 69 SPAIN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 70 SPAIN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 71 SPAIN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 72 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 73 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 74 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 75 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 76 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 77 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2018-2030 (USD BILLION)

TABLE 78 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 79 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 80 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 81 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 82 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 83 CHINA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 84 CHINA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 85 CHINA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 86 CHINA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 87 CHINA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 88 JAPAN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 89 JAPAN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 90 JAPAN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 91 JAPAN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 92 JAPAN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 93 INDIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 94 INDIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 95 INDIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 96 INDIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 97 INDIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 98 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 99 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 100 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 101 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 102 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 103 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 104 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 105 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 106 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 107 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 108 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 109 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 110 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 111 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 112 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 113 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET, BY REGION, 2018-2030 (USD BILLION)

TABLE 114 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 115 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 116 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 117 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 118 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 119 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 120 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 121 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 122 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 123 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 124 AFRICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 125 AFRICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 126 AFRICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 127 AFRICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 128 AFRICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 129 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2030 (USD BILLION)

TABLE 130 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2030 (USD BILLION)

TABLE 131 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2030 (USD BILLION)

TABLE 132 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2030 (USD BILLION)

TABLE 133 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 134 MAJOR PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

TABLE 135 MOST ACTIVE PLAYER IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

TABLE 136 SERVICE/COMPANY LAUNCH

TABLE 137 MERGER/ACQUISITION

TABLE 138 PARTNERSHIP/COLLABORATION/AGREEMENT

TABLE 139 IBM: SOFTWARE/SERVICES OFFERED

TABLE 140 IBM: KEY DEVELOPMENTS

TABLE 141 ALPHABET INC.: SOFTWARE/SERVICES OFFERED

TABLE 142 ALPHABET INC.: KEY DEVELOPMENTS

TABLE 143 ATOMWISE INC.: SOFTWARE/SERVICES OFFERED

TABLE 144 ATOMWISE INC.: KEY DEVELOPMENTS

TABLE 145 DEEP GENOMICS: SOFTWARE/SERVICES OFFERED

TABLE 146 CLOUD PHARMACEUTICALS, INC.: SOFTWARE/SERVICES OFFERED

TABLE 147 CLOUD PHARMACEUTICALS, INC.: KEY DEVELOPMENTS

TABLE 148 MICROSOFT CORPORATION: SERVICES OFFERED

TABLE 149 INSILICO MEDICINE: SERVICES OFFERED

TABLE 150 CYCLICA: SERVICES OFFERED

TABLE 151 BENEVOLENTAI: SERVICES OFFERED

TABLE 152 EXSCIENTIA: SOFTWARES OFFERED

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

Market Overview
The Artificial Intelligence in Drug Discovery Market is anticipated to register a substantial CAGR of 29.83% during the forecast period. The increasing reception of simulated intelligence in drug discovery, rising key initiatives for man-made intelligence in drug discovery, and the increasing number of man-made intelligence-powered drug discovery new companies are driving business sector development.
The reception of simulated intelligence in drug discovery is rising among industries, including drug and biotechnology organizations. This is essentially owing to the way that artificial intelligence offers progressed benefits to discovering drug particles and paces up the drug discovery process. Further, artificial intelligence gives significant insights to work on the designing, optimizing, and synthesizing of drugs. There are a few factors that are increasing the reception of man-made intelligence for drug discovery. The absolute most predominant ones include the rising incidences of ongoing illnesses and accuracy medicine, owing to the emerging way to deal with the counteraction and treatment of sicknesses. Besides, a few market members are increasing the accuracy of their drug portfolios, a cycle that has been seen to exhibit an increase in the reception of man-made intelligence advancements.
Market Segmentation
Based on product and service Artificial Intelligence in Drug Discovery, is classified into software and services. Based on a molecule type the market is divided into large molecules and small molecules. The Market of Artificial Intelligence in Drug Discovery based on technology is divided into machine learning, deep learning, and others.
Based on an indication the market is classified into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and others. Based on an application the market is categorized into target identification, candidate screening, de novo drug designing, drug optimization and repurposing, and preclinical testing.
Regional Insights
The North American artificial intelligence in the drug discovery market represented the biggest piece of the pie in 2022. This is because of the increasing incidences of ongoing illnesses, many leading new companies, and increasing drug Research and development investments in the region.
Europe's artificial intelligence in the drug discovery market represents the second-biggest piece of the pie because of the rising pervasiveness of uncommon illnesses across Europe and increasing the demand for a simulated intelligence-driven stage for drug discovery. Moreover, Germany's market of artificial intelligence
The Asia-Pacific artificial intelligence in drug discovery market is supposed to develop at a huge offer from 2023 to 2030. This is because of the rising weight of sickness and the tremendous number of biopharmaceutical industries that are adopting computer-based intelligence abilities in the Asia-Pacific region.
The rest of the World is fragmented into the Center East, Africa, and Latin America. Artificial intelligence in the drug discovery market in the previously mentioned regions is probably going to observe development because of the increasing demand for drugs because of the rising incidences of persistent and infectious illnesses.
Major Players
Key Companies in the Artificial Intelligence in Drug Discovery Market include IBM (US), Alphabet Inc (US), Atomwise Inc (US), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc (US), Microsoft corporation (US), Insilico Medicine (China), Cyclica (Canada), BenevolentAI (UK), and Exscientia (UK).

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

Market Research Future社の医薬品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

創薬における人工知能の市場調査レポート 2030年までの予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

Market Research Future社の医薬品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?